Position in INVA
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$5,162,437
+$384,260 QoQ
Shares Held
227,320
+10.8% QoQ
Ownership
0.315%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#51
of 307 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $347,870,398 across 92 Biotechnology names. INVA ranks #10 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
3,433,824 | $186,834,363 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
61,055 | $30,327,850 | |
| 3 | DFTX |
Definium Therapeutics, Inc.
|
396,542 | $18,653,335 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
174,334 | $13,645,122 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
98,687 | $12,097,052 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
32,399 | $9,232,743 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,594 | $7,852,862 | |
| 8 | ARGX |
Argenx SE
|
7,699 | $7,142,901 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,162,437 | 227,320 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $4,778,177 | 205,072 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,704,526 | 185,319 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,253,993 | 178,301 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,262,575 | 162,398 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,161,654 | 174,388 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,895,350 | 166,879 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,990,925 | 154,890 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,422,640 | 147,722 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,148,337 | 140,967 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $913,301 | 56,939 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $711,267 | 54,755 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $671,456 | 52,746 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $599,557 | 53,294 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $532,040 | 40,154 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $516,935 | 44,525 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,447,587 | 98,075 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,707,966 | 88,267 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,523,295 | 88,307 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,284,013 | 76,841 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $936,822 | 69,860 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $739,095 | 61,849 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $565,145 | 45,613 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $399,357 | 38,216 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $164,111 | 11,739 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||